The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Prout Samantha since 2020.
This trader's CIK number is 1743122.
At the time of last reporting, Prout Samantha was the Chief Accounting Officer of Amicus Therapeutics, Inc.. (stock ticker symbol FOLD).
Also see all insider trading activities at Amicus Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | FOLD | 0 | $0 | 32,104 | $449,548 | 0 | $0 |
| 2023 | FOLD | 0 | $0 | 44,568 | $624,173 | 36,909 | $385,071 |
| 2021 | FOLD | 0 | $0 | 9,970 | $114,663 | 4,925 | $48,240 |
| 2020 | FOLD | 0 | $0 | 12,625 | $213,174 | 9,693 | $111,668 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-01-08 | FOLD | Sale | 30,767 | 14.00 | 430,830 |
| 2024-01-09 | FOLD | Sale | 1,337 | 14.00 | 18,718 |
| 2023-12-26 | FOLD | Sale | 7,659 | 14.00 | 107,226 |
| 2023-08-09 | FOLD | Option Ex | 36,909 | 10.43 | 385,071 |
| 2023-08-09 | FOLD | Sale | 36,909 | 14.01 | 516,947 |
| 2021-09-03 | FOLD | Option Ex | 4,925 | 9.79 | 48,240 |
| 2021-09-03 | FOLD | Sale | 4,925 | 12.01 | 59,168 |
| 2021-08-23 | FOLD | Sale | 5,045 | 11.00 | 55,495 |
| 2020-11-04 | FOLD | Option Ex | 5,931 | 12.46 | 73,900 |
| 2020-11-04 | FOLD | Sale | 5,931 | 20.00 | 118,620 |
| 2020-08-05 | FOLD | Option Ex | 198 | 10.04 | 1,987 |
| 2020-08-05 | FOLD | Sale | 198 | 15.05 | 2,979 |
| 2020-07-02 | FOLD | Option Ex | 198 | 10.04 | 1,987 |
| 2020-07-02 | FOLD | Sale | 198 | 15.80 | 3,128 |
| 2020-06-19 | FOLD | Option Ex | 3,366 | 10.04 | 33,794 |
| 2020-06-19 | FOLD | Sale | 3,366 | 15.00 | 50,490 |
| 2020-06-16 | FOLD | Sale | 2,932 | 12.95 | 37,957 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Prout Samantha (Chief Accounting Officer of Amicus Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.